We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$976M
1-Year Est. Return
66.76%
This Fund
S&P 500
This Quarter
Est. Return
+16.38%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$2.3B
AUM Growth
+$74.7M
(+3.4%)
Cap. Flow
+$189M
Cap. Flow
% of AUM
8.22%
Top 10 Holdings %
Top 10 Hldgs %
31.66%
Holding
197
New
49
Increased
45
Reduced
38
Closed
57
Avg Time Held Equity + Options
2.1
quarters
Top 10 Avg Time Held Equity + Options
0.7
quarters
Top 20 Avg Time Held Equity + Options
1
quarter
Avg Time Held Equity only
2.2
quarters
Top 10 Avg Time Held Equity only
0.4
quarters
Top 20 Avg Time Held Equity only
1.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visteon
VC
|
+$86.3M |
| 2 |
Apple
AAPL
|
+$59.3M |
| 3 |
Tyson Foods
TSN
|
+$56.2M |
| 4 |
CDK
CDK Global, Inc.
CDK
|
+$49.5M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$49.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$99.3M |
| 2 |
WFT
Weatherford International plc
WFT
|
+$54.3M |
| 3 |
Lowe's Companies
LOW
|
+$38.3M |
| 4 |
Nabors Industries
NBR
|
+$27.3M |
| 5 |
Cemex
CX
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.72% |
| 2 | Healthcare | 20.5% |
| 3 | Technology | 14.65% |
| 4 | Consumer Discretionary | 9.4% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
iShares Russell 2000 ETF
IWM
$77.9B
| $95.7M | 4.16% |
800,000
-1,030,000
| -56% | -$118M |
2014 Q3
1 quarter
|
|
|
2
Visteon
VC
$2.31B
| $95.5M | 4.15% |
+893,989
| New | +$86.3M |
2014 Q4
0 quarters
|
|
|
3
Tyson Foods
TSN
$18.9B
| $82.6M | 3.59% |
2,061,500
+1,386,500
| +205% | +$56.2M |
2014 Q2
2 quarters
|
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $78.3M | 3.4% |
6,074,616
+3,927,012
| +183% | +$49.2M |
2013 Q2
6 quarters
|
|
5
PUT
iShares Biotechnology ETF
IBB
$10.2B
| $75.8M | 3.3% |
+750,000
| New | +$72.9M |
2014 Q4
0 quarters
|
|
6
Micron Technology
MU
$1.08T
| $64.9M | 2.82% |
1,853,300
+907,300
| +96% | +$30M |
2014 Q2
2 quarters
|
|
7
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $61.7M | 2.68% |
300,000
-685,000
| -70% | -$138M |
2013 Q2
6 quarters
|
|
|
8
Apple
AAPL
$4.98T
| $60.2M | 2.62% |
+2,180,400
| New | +$59.3M |
2014 Q4
0 quarters
|
|
|
CDK
9
DELISTED
CDK Global, Inc.
CDK
| $57M | 2.48% |
+1,397,700
| New | +$49.5M |
2014 Q4
0 quarters
|
|
10
CBRE Group
CBRE
$37.5B
| $56.7M | 2.47% |
1,656,782
+656,782
| +66% | +$21M |
2014 Q2
2 quarters
|
|
|
AGN
11
DELISTED
Allergan plc
AGN
| $48.8M | 2.12% |
189,569
+128,100
| +208% | +$32M |
2013 Q3
5 quarters
|
|
|
AGN
12
DELISTED
Allergan Inc
AGN
| $42.3M | 1.84% |
198,750
+50
| +0% | +$9.94K |
2014 Q3
1 quarter
|
|
13
United Airlines
UAL
$33.5B
| $41.4M | 1.8% |
618,200
+383,200
| +163% | +$21.2M |
2014 Q3
1 quarter
|
|
14
CALL
Citigroup
C
$209B
| $40.6M | 1.76% |
750,000
-400,000
| -35% | -$21.2M |
2013 Q2
6 quarters
|
|
15
Palo Alto Networks
PANW
$325B
| $38.3M | 1.66% |
1,873,800
-136,200
| -7% | -$2.51M |
2014 Q1
3 quarters
|
|
16
Vanda Pharmaceuticals
VNDA
$260M
| $35.2M | 1.53% |
2,461,305
+656,125
| +36% | +$7.76M |
2013 Q2
6 quarters
|
|
17
CDW
CDW
$19B
| $33.9M | 1.47% |
+964,400
| New | +$31.2M |
2014 Q4
0 quarters
|
|
18
DELISTED
SUNEDISON, INC COM
SUNE
| $33.6M | 1.46% |
1,724,400
+574,400
| +50% | +$10.9M |
2014 Q3
1 quarter
|
|
19
PUT
Invesco QQQ Trust
QQQ
$497B
| $33M | 1.44% |
+320,000
| New | +$32.4M |
2014 Q4
0 quarters
|
|
|
ANAC
20
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $32.9M | 1.43% |
1,019,275
+91,521
| +10% | +$2.75M |
2013 Q2
6 quarters
|
|
|
QLIK
21
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $29.9M | 1.3% |
967,500
+117,500
| +14% | +$3.35M |
2014 Q1
3 quarters
|
|
22
DELISTED
Time Inc.
TIME
| $29.5M | 1.28% |
+344,800
| New | +$7.8M |
2014 Q4
0 quarters
|
|
|
TERP
23
DELISTED
TerraForm Power, Inc
TERP
| $28.3M | 1.23% |
917,600
+597,600
| +187% | +$17M |
2014 Q3
1 quarter
|
|
24
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.71B
| $28M | 1.22% |
+450,000
| New | +$25.7M |
2014 Q4
0 quarters
|
|
25
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$3.28B
| $26.5M | 1.15% |
650,000
-100,000
| -13% | -$3.92M |
2014 Q2
2 quarters
|
|
Similar funds
PHP
ACM
FM
PFGIA
PAMI
SI
ZI
RIA
Kingdon Capital Management's Q4 2014 Portfolio in Review
As of Q4 2014, Kingdon Capital Management held 197 positions worth $2.3B, up 3.4% from $2.23B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Kingdon Capital Management deployed $189M of net new capital in Q4 2014, opening 49 new positions and adding to 45 existing holdings. Its largest new stake was Visteon: 893,989 shares worth $95.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 39% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was HCA Healthcare, an estimated $99.3M trimmed.
- Kingdon Capital Management's largest Q4 2014 buy was Visteon: 893,989 shares worth $95.5M.
- Kingdon Capital Management added most to Tyson Foods in Q4 2014, an estimated $56.2M increase.
- Kingdon Capital Management's biggest Q4 2014 reduction was HCA Healthcare, cutting an estimated $99.3M.
- Kingdon Capital Management fully exited Weatherford International plc in Q4 2014, selling an estimated $54.3M.
- Kingdon Capital Management's ten largest holdings make up 32% of its $2.3B portfolio in Q4 2014.
- Kingdon Capital Management opened 49 new positions and closed 57 in Q4 2014.
- Kingdon Capital Management's portfolio value rose 3.4% quarter-over-quarter to $2.3B.
Based on Kingdon Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.